Microbot soars on tie-up with Stryker to develop robotic procedural kits

Microbot Medical

27/12/2021 15:05

(Updates share movements, adds milestone)
    ** Shares of medical devices co Microbot Medical Inc
 MBOT.O  soar ~72% to $9.30; their highest in more than
one-and-a-half months
    ** Stock top percentage gainer across U.S. exchanges 
    ** Co to partner with medical technology co Stryker Corp
 SYK.N  
    ** Says to integrate Stryker's neurovascular instruments
with MBOT's Liberty Robotic System to develop robotic procedural
kits for use in certain neurovascular procedures  urn:newsml:reuters.com:*:nGNX3j8Lg2 
    ** Co will continue to develop the Liberty system
independently for use in peripheral and coronary procedures
    ** Pre-clinical studies of Liberty system showed its
potential to allow physicians to safely and efficiently conduct
certain types of remote vascular procedures, and reduce the risk
for radiation exposure, physical strain on the user and Hospital
Acquired Infections - MBOT
    ** Including session moves, stock has risen ~36% YTD 

 (Reporting by Oishee Majumdar in Bengaluru)
 ((oishee.majumdar@thomsonreuters.com;))